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ABSTRACT

TOWARDS STRUCTURAL DETERMINATION OF HUMAN α1-GLYCINE
RECEPTOR ALLOSTERY

By
Rathna J Veeramachaneni
May 2016

Dissertation supervised by Dr. Michael Cascio
Recent advances in technology have led to the determination of numerous notable
structures of membrane proteins. While they provide valuable information about the
structure of membrane proteins these studies often provide static images with potentially
limited dynamics, and structural determination often requires truncation of flexible regions,
and often utilizes bacterial homologs given the need for stable, heterologous
overexpression. In order to better understand allostery at a molecular level, state-dependent
crosslinking studies coupled with multidimensional mass spectrometry (MS) were
conducted on glycine receptor (GlyR) stabilized in different allosteric states. Predominant
allosteric states were stabilized using wild type or mutated receptor in the presence of
selected ligands: resting (no ligand), desensitized (saturating glycine) and open state (nondesensitizing

ivermectin

(IVM)-gated

F207A/A288G

iv

GlyR).

Photo-crosslinking

methodology linked with mass spectrometric analysis was developed on systematically
generated single Cys mutations in GlyR with both Cys null and IVM sensitive backgrounds
to enable the study of state-dependent structures of GlyR in comparative crosslinking
studies. Studies were conducted on A41C and H419C mutants. A41 is shown to be in
proximity to the pre-M1 and the M2-M3 loop region crucial for gating. Prior to these
studies, very little information on H419 was available as it is located in C-terminal tail of
the receptor that is often truncated in structural studies conducted on other related
pentameric ligand-gated ion channels. These studies identified specific GlyR crosslinks
unique to each conformational state and identified potential motions in the receptor upon
gating and desensitization. The defined distance constraints will be used to update our
model of human α1-GlyR and provide insight into channel function. Significantly, this
methodological approach is amenable to study any allosteric protein and complement other
high resolution structural studies in identifying protein dynamics.
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CHAPTER 1
TOOLS FOR THE STRUCTURAL DETERMINATION OF
CHANNELS AND TRANSPORTERS

1.1.

Introduction

Membranes consist of a lipid bilayer that provides permeability barriers for ions, water,
and biomolecules, thereby protecting the cell by separating compartments between the
inside and outside of cells in the case of the plasma membrane, or allowing sequestration
of ions and biomolecules between cellular compartments in the case of the membranes of
organelles. Both prokaryotes and eukaryotes possess an exterior plasma membrane that
regulates the type and amount of substances that enter the cell. Eukaryotes however have
additional internal membrane that organize the cellular components and regulate their
movement within the cell. Plasma membranes have a specialized structure and act as
barriers in letting molecules pass and in relaying messages in and out of the cells when
triggered by molecular events. Membrane proteins are the proteins that are embedded in
the cell membrane that are involved in various cellular functions including transport of
ions, water and/or biomolecules, cellular adhesion, cellular signaling and motility and
cellular identification. Approximately a third of all proteins encoded in the human body
are membrane proteins [1]. A subset of these proteins act as transporters involving the
passive or active transport of various molecules including amino acids, ions and water [2].
The diversity (channels, receptors) and the vital functions of this class of membrane
proteins identified them as a prime targets for drug development and biological research.
Approximately 50% of the drugs on market targets membrane proteins [3]. This chapter
will survey the different biochemical and biophysical tools used to experimentally
determine membrane protein structure. In the interest of narrowing examples utilizing these
methods, the discussion will be focused to how these methods have been utilized in the
study of integral membrane proteins that are channels and transporters.
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1.2. The composition of membranes and types of membrane proteins
The lipid composition of the membranes is comprised of phospholipids, glycolipids and
sterols. The non-covalent association and arrangement of these lipids and their respective
membrane proteins gives the membrane its shape. All membrane lipids consist of a
hydrophobic tail and hydrophilic head and spontaneously associate to from a lipid bilayer
composed (with each layer defined as a leaflet). The polar, hydrophilic head of lipids are
oriented outwards and accessible to the aqueous environment. The non-polar hydrophobic
tails prefer to be sequestered away from water, so they are closely packed in the interior of
the bilayer and interact with each other [4]. The dynamic nature of lipid membranes,
described by Singer and Nicholson as the fluid mosaic model, is influenced by the physical
properties of individual lipid components [5]. Lipid composition can impact the interface
between lipids and proteins thereby affecting the membrane protein activity [6, 7]. For
example, the plasma membrane contains an abundance of choline-containing
phospholipids lining the outer monolayer of the membrane and the amine-containing lipids
preferring the inner monolayer. The phospholipids including phosphatidylcholine,
sphingomyelin, phosphatidylethanolamine, and phosphatidylserine along with cholesterol
give rise to asymmetric organization with different chemical and dynamic environments
between the monolayers of the membrane as they differ in size, charge, polarity and
reactivity [8, 9]. The interactions in the monolayers between cholesterol and sphingolipids
are thought to result in transient submicro- or nano- sized lipid rafts. Lipid rafts have a
short half-life of 10-20ms which then undergoes changes and result in large signaling rafts
[10]. Recent evidence suggests that some integral membrane proteins have different
affinities in lipid raft association, providing mechanisms for lateral heterogeneity and
clustering of these proteins in membranes as a function of local composition [11].
Some membrane proteins sit on the surface (peripheral membrane proteins) while
others are anchored in the membrane (integral membrane proteins) and have domains
present on one or both sides of it. Proteins that consist of domains inside the cell in general
have the broader range of functions including intracellular signaling and anchoring of other
proteins present inside the cell. The function of any protein is determined by its structure.
Based on their location and function membrane proteins are majorly classified into integral

3

proteins that are embedded within the hydrophobic layer of the membrane, peripheral
proteins that are associated with the hydrophilic heads in most and lipid-linked proteins
that are incorporated into large lipid domains via a covalent attachment to one or more lipid
groups [12, 13].
Integral membrane proteins consist of one or more stretches of contiguous amino
acids that are embedded in the membrane and these segments are typically comprised of
hydrophobic amino acids. Transmembrane proteins have domains comprised of
hydrophilic amino acids that project from either side of the lipid bilayer in which they are
embedded [14]. Transmembrane proteins are grouped based on the number of times they
cross the membrane. Channels and pores are members of this class of protein. Peripheral
membrane proteins associate with the membrane via weak non-covalent interactions, either
with the lipids or with other membrane proteins and may be extracted in an aqueous soluble
form without perturbing the integrity of the membrane (unlike integral membrane
proteins). Peripheral proteins function as a part of the cytoskeleton or aid in signal
transduction and cell to cell communication between cells. Unlike integral and peripheral
membrane proteins, lipid-linked proteins have lipids covalently attached and these lipids
integrate into the membrane, linking the protein to the bilayer. Some lipid linkages are
known to associate with lipid rafts and are incorporated into detergent insoluble glycolipid
enriched complexes. As lipid rafts are enriched in cholesterol and sphingolipids, lipidlinked proteins are influenced by the levels of cholesterol present in the body [15]. Many
lipid-linked proteins play key roles in intracellular signaling [12].
1.3. The role of membrane proteins in health and disease
Considering the vital role of membrane proteins, dysfunction of this class of proteins can
cause disease. Changes in phenotype may arise due to over- or under- expression of the
protein in the membrane, and loss or gain of function. Dysfunction of the membrane
proteins can result in various conditions including type 2 diabetes, epilepsy, cystic fibrosis,
cardiac arrhythmias and depression [16, 17]. Misfolding of the membrane proteins and
their overproduction can also lead to diseases including Parkinson’s, Huntington’s,
Alzheimer’s and Creutzfeldt-Jakobs Disease, as well as many types of cancers [18].
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30% of the proteins produced in the human body are membrane proteins [19].
About a third of the drug targets identified in literature are membrane bound proteins
including G-protein coupled receptors, membrane transporters, ion channels and receptors
coupled to intracellular proteins [20, 21]. The activity of these membrane proteins is
regulated either directly or indirectly by other proteins via protein-protein interactions,
post-translational modifications (PTMs) and by the binding of small molecules. G-protein
coupled receptors (GPCRs) and ABC transporters are over expressed in various cancers
and also play a major role in the resistance to anticancer drugs [22-24]. In most of the cases
membrane proteins are the first ones to be effected by the disease state as they reside on
the cell surface. This could result in the membrane proteins dislodging from the cell surface
into the biological fluids. Their presence in fluids may be used as biomarkers in diagnosis
and in choosing a treatment option. The concentrations of over 370 plasma membrane
protein candidates have been used as biomarkers for disease and more potential candidates
are being continually added to the list [25].
Another major role of membrane proteins is their role in cellular signaling. Ion
channels, transporters, enzyme linked receptors and GPCRs are classes of membrane
proteins that enable signal transduction across the plasma membrane by the conversion of
extracellular transmission into intracellular responses. In the case of ion channels, based
on the signal whether it be, binding of signal molecule, sensing a neurotransmitter or
recognizing voltage gradient and membrane potential these membrane proteins undergo a
conformational change. This conformational change then allows for specific ions to pass
through thereby exerting a cellular response [26]. Any dysregulation in the function of the
ion channels embedded in the cell membrane can result in disorders. These disorders in ion
channels are further grouped as channelopathies and are primarily due to mutations in
genes encoding ion channels. As ion channels are located in membranes of the cells and
most of the cellular organelles, channelopathies affect systems including nervous system,
cardiovascular, respiratory, endocrine, urinary and immune systems [27]. One such
channelopathy is hereditary hyperekplexia, a startle disease caused by the mutations that
alter heteromeric α1β glycine receptor (GlyR) function [28]. At least 29 ion channel genes
are identified to have mutations that correspond to ion channel channelopathies [29].
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Several pathogenic diseases including cardiovascular, neurodegenerative,
metabolic, tumerogenesis arise as a result of miscommunication in the cellular machinery
and misregulation of cellular signaling [30]. Of these membrane proteins GPCRs are a
major player in signal transduction. Various lipid mediators including PGs, leukotrienes,
lysophospholipids, sphingosylphosphorylcholine bind to GPCRs as ligands and initiate a
lipid-mediated signaling pathway by activating PKC and increasing the intracellular Ca2+
and also by β-arrestin coupled pathways among other functions [31-33].
Membrane proteins also have a role to play in energy metabolism in the conditions
such as oxidative stress and mitochondrial defects. Impaired energy metabolism reduces
the amount of high-energy phosphates in the cells which in turn results in reduction of the
membrane potential. Voltage sensitive Mg2+ NMDA receptors are then activated by
endogenous glutamate to maintain the membrane potential of the cell [34]. This persistent
activation of NMDA receptors due to metabolic defects may result in neuronal death via
excitotoxic mechanism [35]. This neuronal death may result in Huntington’s disease and
Parkinson disease [36]. Drugs that can act as excitatory amino acid antagonists and drugs
that can improve neuronal bioenergetics are needed to treat these disorders [37, 38].
Many toxins from the venoms of snakes, scorpions, spiders, marine snails and bees
bind to voltage sensitive ion channels and alter/inhibit the channel gating [39-41]. Toxins
can be divided into non-peptide and peptide toxins. Non-peptide toxins are mostly obtained
from plants, fish, algae or any organism that accumulates alkaloids through their diet. On
the other hand, peptide toxins are isolated from the ducts of poisonous creatures ranging
from 8-70 amino acids and are stabilized by disulfide bonds or hydrogen bonding. Some
toxins form toxin-channel complexes thereby influencing the structure and dynamics of the
lipid bilayer [42]. Considering the inherent enormous potential for toxin mimetics in the
treatment of various neurological disorders including epilepsy, cancer, cardiovascular
disorders, and pain studies on the different toxin-channel interactions may enable the
design of potent, selective therapeutics [43, 44].
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1.4. Structural determination of membrane proteins
Many membrane proteins are expressed in their natural environment in very low quantities,
making it challenging to determine their structure. In order to understand the structure of
the membrane proteins, it is often necessary to overexpress the protein or determine the
structure of homologs, often bacterial, that can be harvested from native sources or
recombinantly expressed in large quantities. Many eukaryotic membrane proteins are
overexpressed in insect cells, yeast or mammalian cell systems [45]. Eukaryotic membrane
proteins are typically assembled in endoplasmic reticulum (ER) and are delivered to their
appropriate membrane via trafficking mechanisms. As prokaryotes lack organelles and
much of the co-translational machinery used in assembling and trafficking of eukaryotic
membrane proteins, generally necessary to utilize eukaryotic overexpression system for
membrane proteins in spite of the ease and cost effectiveness in prokaryotic expression
[46]. Comparative overexpression studies of the same eukaryotic membrane protein in both
prokaryotic and eukaryotic cell lines have shown that eukaryotic cell lines such as insect
and mammalian cell lines produced lower quantities as compared to prokaryotic expression
system, but were better able to produce functional proteins. In particular, insect cell lines
(Sf-9 cells) appear to be an ideal expression system for the successful production of
functional membrane proteins with specific post translational modifications [47]. Once the
proteins are expressed and inserted into membrane the membrane protein fractions are then
subjected to purification via solubilization and separation from other endogenous proteins
in the cell [48].
Many integral membrane proteins are large multi-subunit complexes that function
in signal transduction. These proteins are allosterically modulated and sample multiple
conformational states. Their dynamic nature makes them difficult to crystallize to
determine the structure of these membrane proteins. Nonetheless, there have been crystal
structures of membrane proteins in literature often co-crystallized with unnatural substrates
or antibodies that might alter their structure [49, 50]. Many of these crystal structures in
literature omit some of the protein segments and substitute them with new segments to aid
in purification, stability, or crystallization. For example, 33 residues from the cytoplasmic
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tail of bacterial K+ channel were removed to aid in crystallization and the M3-M4
intracellular loop was removed in studies of human GABAR [51, 52].
Also, many membrane proteins will not function and will not fold correctly unless
they are surrounded by appropriate lipids. This requirement of membrane proteins limits
the use of many biophysical methods typically used to determine the structure of soluble
proteins at high resolution, such as X-ray crystallography and nuclear magnetic resonance
(NMR) spectroscopy. Other methods commonly used for the determination of membrane
protein structure include electron microscopy (EM), Forster resonance energy transfer
(FRET), electron paramagnetic resonance (EPR), and mass spectrometry (that may be
coupled with H-D exchange or crosslinking studies). These methods, along with their
benefits and restrictions in the determination of membrane protein structure, are briefly
discussed below. A wide range of challenges remain in the experimental determination of
membrane proteins due to problems including poor overexpression Computational
approaches have been developed as a complimentary method to advance our understanding
towards membrane protein structure. Major methods used to determine the structure of
membrane proteins are abinitio modeling to predict protein folding, fold recognition
technique that generate low resolution structures of proteins based off of a low
identical/similar known structure, homology modeling to build high resolution unknown
structures based on high sequence similarity of known structure and MD simulations to
understand the structural effect on the function of the proteins. Computational studies also
aid in refining structures obtained from experimental studies such as x-ray crystallography,
NMR and cryo-EM [53].
1.4.1. X-Ray Crystallography
X-ray crystallography requires high-purity non-heterogeneous preparations of protein that
may then be crystallized. Relative to soluble proteins, membrane proteins provide an extra
obstacle to crystallization in that they must be solubilized from the membrane. The
detergents used to solubilize the proteins add another experimental variable to the
multivariate crystallization trials and the hydrophobic contacts of the protein to the
detergent can lead to poor crystal contacts. The use of antibodies in crystallization trials
has been found to provide good protein-protein contacts and be helpful in the crystallization
8

of some membrane proteins [54, 55], but these may lead to structural artifacts. Eukaryotic
membrane proteins are not expressed at high levels endogenously and often not
heterologously expressed in functional form in bacteria. This can limit the quantities of
protein sample to subject it to crystallization. The hydrated crystals are subjected to an
intense beam of X-rays. The crystallized well-ordered protein diffracts the X-ray beam into
a characteristic pattern of spots. The diffraction patterns as a function of the crystal
orientation are further analyzed to determine the distribution of electrons in the protein.
The resulting electron density map is then interpreted to determine the location of every
electron-dense atom. Available information about the protein such as the sequence,
preferred geometry of bond lengths and bond angles in a typical protein are taken into
account to determine the location of each non-hydrogen atom and, a model consistent with
these data is built. The coordinate file for a particular protein consists of the atomic
positions of the residues in the protein relative to each other. The resolution with which the
protein structure is resolved via x-ray crystallography determines how well the atom
location fits into the model. The R-value measures how well the fitted atomic model
supports the experimental data obtained for the protein at this resolution [56].
The advantages of using X-ray crystallography is that it can give detailed high
resolution information about the location of residues in the protein along with other
molecules including ligands, metal ions, ions and other substituents that are crystallized
with the protein. It can provide information including the ligand binding site, proteinprotein interactions, different states exhibited by the protein provided that the protein is
crystallized in that desired state. However flexible proteins, or portions of the biomolecular
complex that are flexible, pose a challenge to be resolved using x-ray crystallography as
they are difficult to crystallize or poorly resolved in the crystal structure. While rigid
proteins can form ordered crystals that repeats the unit cell with the same exact orientation
can be well resolved, the dynamic part of the membrane protein makes it difficult to
crystallize thus resulting often in smeared electron density maps yielding structures that
are less well-resolved, if resolved at all. In many cases the flexible portions of
heterologously expressed proteins are either removed or substituted with a rigid portion to
aid in crystallization [57]. The crystal structures are able give only static images of the
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proteins thereby giving only partial information about the structure and function of
membrane proteins. The crystals formed due to the dynamic nature of the membrane
proteins are fragile due to hydrophobic contacts and results mostly forming poor crystals.
The quality of the crystals determine the accuracy of the atomic structure obtained with
well-ordered crystals providing a more accurate depiction of the atomic structure. Many
proteins undergo co- and post-translational modification, with glycosylation being a
common modification of membrane proteins. These modifications are often heterogenous
within a given protein population. Heterogeneity of glycosylation can be especially
problematic for the growth of high quality crystals for x-ray diffraction. In order to preserve
the protein homogeneity, sites of glycosylation are often either mutated or glycosylation is
limited by the addition of glycosylation inhibitors or by treating the protein with glycanases
after protein purification. The use of robotics to automate crystallization trials, storing,
mounting, aligning of the crystals and collecting data sets has helped speed up the data
collection and analysis of x-ray diffraction studies. Another major advantage of robotics is
miniaturization immensely reduced the requirement of the volume of protein samples to
few nanoliters [58, 59]. Despite these advances, membrane proteins remain poorly
represented in the protein data base.
1.4.2. Nuclear Magnetic resonance (NMR) Spectroscopy
NMR spectroscopy is another powerful technique that can be used to determine the
structure of proteins at the atomic level. Once the protein is overexpressed and purified, it
is subjected to a strong magnetic field, and is then probed with radio waves. The unique
resonance sets obtained are processed and based on the amino acid sequence, atomic nuclei
with unpaired spin states can be identified in the resultant spectra and a model depicting
the bonding and local conformation of these atoms can be built. This obtained model gives
information on location of each spin active atom (e.g. 1H, 13C, 15N) with respect to other
nuclei present in the protein. More than a hundred of structures of small and medium sized
proteins (<50kDa) are determined by NMR (http://www.drorlist.com/nmr/MPNMR.html),
but is scarcely used on large proteins as the proteins pose problems such as overlapping
peaks as the number of signals increase with molecular weight in the NMR spectra
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[60]. This complexity increases the likelihood of resonance overlap, making it difficult to
obtain site-specific information using NMR [61].
A benefit of NMR studies is that the protein is examined in solution, allowing the
high-resolution determination of structures of flexible proteins at atomic level [62]. An
ensemble of structures are generated in NMR studies, the rigid regions in the protein give
a strong signal whereas the flexible regions are less constrained and do not give a strong
signal in the experiment. This ensemble of structures is then minimized to an average
structure. This structure gives information on disulfide bonds, hydrogen bonding and stereo
chemical information of the chains present. However, with respect to membrane proteins,
the presence of the membrane is problematic as the samples do not tumble. In addition,
NMR requires a very concentrated pure sample that is hard to achieve with low endogenous
levels of eukaryotic proteins and limitations of bacterial expression of non-functional
eukaryotic proteins [63]. Recent advances in NMR spectroscopy including developments
in isotope labeling, increase of magnetic field strength, common use of a cryogenic probe,
design of pulse sequences have provided many clues into channel gating and
conformational transitions [64]. Conformational changes relating to binding and lobe
closure in S1S2 domain of ionotropic glutamate receptors (GluR2) are identified using 19F
NMR spectroscopy [65]. NMR structure of TMD of human glycine receptor (hGlyR-α1)
revealed unique and dynamic structural features of anion selective Cys-loop receptors [66].
1.4.3. Electron Paramagnetic Resonance (EPR) Spectroscopy
Electron paramagnetic resonance (EPR) also called electron spin resonance spectroscopy
(ESR) is a magnetic resonance spectroscopy that utilizes microwave radiation of unpaired
electrons in the presence of a static magnetic field. EPR works on the principle of
determination of distance histograms between pairs of spin-labels covalently bound to a
protein. EPR uses electron spin properties while NMR works based on nuclear spins. EPR
spectroscopy can provide long distance structural measurements of membrane proteins.
Double electron-electron resonance (DEER)/EPR spectroscopy can measure 20-80 Å
distances by measuring the dipolar coupling between two unpaired electron spins. Poor
DEER modulation in liposomes with proteins and shorter transverse relaxation times (T2)
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has led to the development of using spin labels in DEER-EPR experiments. However, EPR
procedure needs to be performed at low temperatures (as low as 4.2k) in order to detect
free radical electrons. Recent introduction of sample prep and handling techniques
including low protein/lipid molar ratio, usage of nanodiscs in reconstituting unlabeled
proteins, using bi-functional spin labels and pulsed EPR has reduced the major limitations
of DEER-EPR such as phase memory times and signal sensitivity [67, 68]. The structural
information obtained from these experiments are combined with a recently developed
restrained molecular dynamics simulation computational modelling methods and was used
to determine and refine the resting state model of the voltage sensing domain (VSD) of
potassium channel (Kv1.2) [69].
EPR experiments are emerging as a potential method in the structural determination
of membrane proteins. Pulsed DEER-EPR analysis of the C-terminal domain of cation
potassium channel KcsA revealed the dynamic and flexible nature of the activation gate
[70]. EPR spectroscopic study on the anion channel α1-hGlyR identified the binding site
of Cu+2 and showed that pentameric GlyR can have five Cu+2 ions bound suggesting one
binding site per subunit [71]. Studies using site-directed spin labeling (SDSL) electron
paramagnetic resonance (EPR) spectroscopy on purified GLIC a reconstituted in liposomes
showed few molecular arrangements in channel gating advancing the understand of
molecular mechanisms of pLGICs [72]. The limitations of EPR is the requirement of
relatively large amount of purified protein to conduct the studies, and the need to attach
exogenous spin labels.
1.4.4. Cryo-Electron Microscopy (Cryo-EM)
Recent advances in electron microscopy (EM) have increased its utility in the
determination of the structures of large macromolecular complexes [73]. Cryo-EM can be
used to look into the secondary structure crystals by electron scattering and then predict
the structure and arrangement of the membrane proteins [74]. The electron beam is used to
image the molecules that are preserved in vitreous ice. Preservation of structures in ice
provides an aqueous environment to be preserved around the molecule, allowing study of
the protein under native-like conditions. Cryo fixation also helps reduce the radiation
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damage and limits the structural changes that may occur during data collection. Samples
are typically either frozen close to liquid nitrogen temperatures into thin films or vitrified
using high pressure systems. 3D density maps can be generated on the proteins that are
packed symmetrically in a membrane using electron diffraction. These density maps are
further aligned and an average image is generated [75].
There are few disadvantages associated with Cryo-EM, low signal to noise ratio
when dealing with macromolecules as their ability to absorb electrons is very low. It is a
difficult process to make vitreous ice and if it is not formed the sample is then embedded
in cubic ice which damages protein structure [76]. Cryo-EM is a time consuming process,
but recent advances in computational power overcame the partial need for crystalline arrays
by single particle reconstruction techniques. The cryo-EM structure of full-length MloK1,
a cyclic nucleotide-modulated potassium channel provided insight into arrangement of
cyclic nucleotide-binding domains in the full-length channel in the absence and presence
of ligand [77].
1.4.5. Forester resonance Energy Transfer (FRET)
FRET studies are based on the distance-dependent non-radiative energy transfer between
appropriate donor and acceptor molecules. FRET can be due to fluorescence or
luminescence energy transfer. The donor and acceptor pair is chosen based on the overlap
of the emission spectra of a donor and the absorption spectra of the acceptor. The donor
and acceptor molecule are typically attached via disulfide bond or to the tags added at the
sites of interest. Typically, the donor molecule is a dye or a chromophore that absorbs the
energy then transfers it non-radiatively to an acceptor chromophore. This results in
decrease of donor’s fluorescence intensity and lifetime, and in increase of acceptor’s
emission intensity. Photons are not emitted by the donor but the energy is transferred to the
acceptor molecule whose electrons become excited and can return their ground state by
emitting a photon. Forster determined that the efficiency of FRET process (E) can be
obtained from the inverse of the sixth distance between the donor and acceptor [78]. The
proximity must be between 10-100 Å for measurable FRET. As described above, the
excitation spectrum of acceptor must overlap with the emission spectra of donor, the degree
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of overlap being the spectral overlap integral (J). Transition dipole orientations of the donor
and acceptor must also be parallel (k2). k2 is an orientation factor that is a function of how
the dipole moment of the donor is angularly oriented with respect to the dipole moment of
the acceptor. The Forster distance (Ro) takes all of the above factors into account in its
calculations [78]. Spectral overlap between the donor and acceptor is an issue while
donor/acceptor pair as both need to have sufficient for the energy transfer but the difference
in spectra should be distinguishable from each other. Analyte concentration plays a key
role in detection of FRET signal. If the concentration of the analyte is low the FRET
activity will be hard to detect even in the presence of large amounts of donor and acceptor.
The donor acceptor pairs also need to be in sufficient concentration for FRET to occur [79].
Most of the binding events of the donors and acceptors are dynamic slowly reaching a
steady state. Therefore, molecules being labelled by one and not so much by the other can
result in no FRET or FRET with high signal-to-noise ratios [80].
FRET signals can be interpreted as a result of a decrease in fluorescence of the
donor or as an increase in fluorescence of the acceptor. The usage of lanthanide compounds
such as europium and terbium allowed for an advancement in recording FRET signal in a
time resolved (trFRET) manner taking advantage of the their longer half-lives and spectral
characteristics there by giving a good signal to noise ratio. Luminescent molecules may
also be used as acceptors (these studies are sometimes referred to as luminescent resonance
energy transfer studies, or LRET) [81, 82]. LRET have benefits over FRET in providing
greater distance accuracy and range as the signal is achieved by distance between the donor
and acceptor rather than their orientation as a result of the unpolarized emission of
terbium/europium chelates that are used as donors [83]. Since the donor emission is long
lived (msec) compared to acceptor emission (nsec), LRET shows a greater improvement
in signal to noise ratio. LRET allows for the measurement of signals in angstrom distances
of changes in protein conformation due to lower background [84].
The distances that can be measured by these methodologies (10-100Å) are
comparable to distances of protein complexes such as between subunits of the proteins, the
diameter of the proteins and the thickness of the membranes [85]. Another important
advantage for FRET measurement is that the measurement is independent of the sensor and
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can also be performed in living cells [86]. The time taken for FRET measurements are short
when compared with most other techniques [87]. FRET studies on GlyBP (mutant GlyR
ECD) compare the inter-subunit distances identifies allosteric changes upon ligand binding
validating GlyBP as a functional homolog for GlyR [88]. LRET studies on a cation
selective model of AMPA subtype of glutamate receptor validated it as a good structural
model to study motions associated with gating upon agonist or partial agonist binding [89].
FRET has the potential to identify the global movements in the membrane protein
allostery. The benefits of FRET include measuring the distances in living cells at a very
low protein concentrations. FRET can be achieved in cells without requiring any
purification if specific labeling of the desired sites can be achieved. The limitations of
FRET include positioning of donor and acceptor molecules within 10 nm distance giving
low-resolution structural information (10-100Å) from the labeled sites. FRET can capture
the global movements but is limited in capturing the subtle local events in the
conformational change [90, 91]. Structural information can only be obtained at the targeted
residue but details on every atom cannot be gained from FRET
1.4.6. Mass spectrometry as a structural tool
Two ionization methods, electrospray ionization (ESI) or matrix assisted laser desorption
ionization (MALDI) are typically employed with a top down or bottom up approach in
proteomic applications [92]. Recent advances in the resolution and sensitivity of MS makes
it a great structural tool to probe into 3-D structures of membrane proteins. MS can be used
for structural determination by coupling with chemical crosslinking, hydrogen (H)deuterium (D) exchange MS, native ESI technique and ion mobility MS [92-95].
Chemical crosslinking is the covalent bond formation between a bifunctional
crosslinking agents and targeted residues within the crosslinking distance in the protein of
interest. Chemical crosslinking can be made possible via various types of crosslinkers
including amine-reactive crosslinkers makes use of the abundantly available lysine
residues in the protein [96, 97], thio-reactive crosslinkers that forms a disulfide linkage
with reactive cysteine that is added via site-directed mutagenesis [98, 99] and carboxylate
reactive crosslinkers that activates carboxyl groups for spontaneous peptide-bond
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formation with primary amines [100]. Typically, a bottom up approach is followed where
the protein of interest is crosslinked and subjected to enzymatic digestion. Mass-shifted
crosslinked peptides are identified by MS. In some studies, additional information is
provided by MS/MS analysis of parent ions to further fragment the peptide to
identify/refine the site of crosslinking. Fragmentation in MS/MS analysis can be obtained
from methods including collision induced dissociation (CID), electron transfer dissociation
(ETD) and electron capture dissociation (ECD). Identifying the site of crosslinking of
different samples stabilized in its general states will yield a network of crosslinks with
distance information. This information can then be used to make models of protein in its
different states that will provide information on protein allostery [101]. One such example
of structural information determined by chemical crosslinking coupled with MS is DMS
induced lysine-lysine crosslinking in studies conducted on GlyBP. A MALDI ionization
coupled with bottom up approach was used to aid in model refinement of GlyBP structure
[102].
Another method that provides structural details is the use of hydrogen/deuterium
exchange to examine accessibility and the structure of proteins. H/D exchange studies
examine the exchange of amide hydrogens in the protein backbone upon incubation of the
protein in deuterated environment followed by rapid quenching. The partially deuterated
protein is subjected to bottom up approach by subjecting it to enzymatic digestion followed
by mass spectrometry. An amide exchange curve is mapped based on the deuterium buildup which then helps in mapping free energy of folding across the protein sequence giving
insight into unique structural and dynamic determination [103, 104]. HDX method is used
to characterize changes in the dynamics of membrane protein ABC transporter in response
to ligand binding or post-translational modifications [105].
Native ESI-MS can be used to detect low abundance molecules with relatively
small mass differences and can be used to study the native proteins in a top down approach.
This method may not generate high resolution data but can be very helpful in classifying
the uncategorized membrane proteins. This method can also be used to identify the
molecular heterogeneity and identify post-translational modifications [94].
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Ion mobility MS works on the principle of separation of protein ions based on their
ability to move through the inert neutrals under the influence of an electric field [106, 107].
Typically, large molecules such as protein ions undergo a more collisions with the inert
neutrals than a small molecular ion. The structure of the ion is achieved by an
electrodynamic ion funnel technology in a high pressure drift tube filled with helium will
allow for the direct calculation of collision cross section (CCS) and gives more control on
the target that is being investigated. Ion mobility not only gives greater separation capacity
as the other LC/MS techniques but preserves the targets and detects them with greater
sensitivity while preserving the resolution capacity. This is achieved by having both ion
mobility and MS dimensions that can probe into structural dimensionality in conformation
space and the ability to perform parallel correlated experiments with limited samples [95,
108]. Ion mobility technique was successfully applied to study the conformation and
oligomerization of Aβ protein implicated in Alzheimer’s disease [109] and α-synuclein
protein associated in Parkinson’s disease [110].
MS is a promising structural tool promising with the aid of computational
modelling tools to integrate the data acquired from all the crosslinking data, H/D exchange
data, multidimensional ion mobility MS data or the traditional ESI-MS data not only give
input for a reliable structural model but also shed insight into dynamics of the membrane
protein in a state dependent manner. Of note, MS has the advantage of requiring very small
amounts of protein. MS can also be a very reliable method to compliment other structural
methods in acquiring and validating structural models.
1.5. Summary

As discussed above, there has been a notable improvement in development and
optimization of the methods that are being used towards determining the structure of the
complex membrane proteins. There is a need more than ever to understand how these
structures look like and how they react to their surrounding environment/stimuli that allow
for the design of potent drugs with minimal side effects with information of their off targets.
In the recent years, MS has evolved as an indispensable technique in the proteomics
research in characterizing proteins and measuring dynamic changes in protein
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conformations and protein-protein interactions. In the following chapters we will describe
our efforts to develop crosslinking coupled with mass spectrometry as a structural tool to
investigate the dynamic structure of the human α1-glycine receptor.

18

CHAPTER 2
Mass Spectrometry Coupled with Crosslinking as a Structural Tool for
Structural Determination of Human α1-Glycine Receptor

2.1. Abstract
The glycine receptor (GlyR) belongs to the family of pentameric ligand gated ion channel
(pLGIC) receptors. These receptors can be excitatory or inhibitory as they respectively,
either depolarize or hyperpolarize the post-synaptic neuron, in fast neuronal transmission.
GlyR is typically an inhibitory receptor that can silence the cellular electrical activity of
the brain and is implicated in chronic pain signaling [111]. While the recent availability of
zebrafish α1-GlyR using cryo-EM, human α3-GlyR bound to strychnine using X-ray
crystallography and open structures of human α1-GlyR using NMR provided insight into
the structure of GlyR, these methods are often limited as they provide static images, often
require large quantities of pure protein and the flexible parts of the protein are often
truncated to aid in these methods [66, 112, 113]. hGlyR is implicated in various
neurological disorders like hyperekplexia and chronic pain [114, 115] and is a target for
anesthetics and alcohols [116]. GlyR exhibits predominantly three states: resting, open
(msec) and desensitized (sec). Chemical crosslinking coupled with mass spectrometry has
the potential to provide structural information of GlyR. This method has the capability of
providing structural information of receptor, requires relatively low protein concentrations
(pmol), and can be applied to a full length receptor without truncating flexible regions.
Single cysteine mutants introduced into Cys null GlyR constructs coupled with
crosslinking and mass spectrometry (MS) will allow aid as a structural tool to study the
structure of human α1-GlyR in the resting state.
2.2. Background
2.2.1 Glycine Receptor (GlyR)
GlyRs are inhibitory ligand-gated receptors that belong to nicotinicoid receptor
superfamily. GlyRs mediate neurotransmission in central nervous system (CNS) and are
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typically activated by glycine. Inhibitory members of the nicotinicoid receptor family (Cysloop family) such as GlyR, glutamate gated chloride channel receptors (GluCIRs) and
GABAA receptors show promising silencing activity as these chloride channels typically
allow passive influx of Cl-, further hyperpolarizing the cell under typical conditions [114].
The receptors in this family are pentamers arranged in a ring around a central ionconducting pore. Each subunit consists of an extracellular N-terminal ligand-binding
domain (ECD), four transmembrane helices (M1-M4) and a intracellular domain, primarily
comprised by the long loop between M3 and M4 [117] (Fig. 1b).
GlyRs are primarily expressed in spinal cord, brain stem, caudal brain, and retina.
In the absence of ligand (glycine), the receptor is essentially in its resting state. Upon
glycine binding, the receptor enters into a short-lived open state, allowing Cl- to pass
through the channel and altering the polarizability of the neurons. The receptor then
transitions to a desensitized state of the receptor where the ligand remains more tightly
bound (relative to the open state) but the channel is in a closed conformation [115].
GlyR can be composed of various combinations of α1, α2, α3, α4 and β subunits.
Typically in most of adult humans, it is found to be composed of two α subunits and three
β subunits [118]. However, expression of human α1 subunits is sufficient to reconstitute
homomeric receptors with native-like function. There are a total of 7 endogenous cysteines
in α1-GlyR, four of which form two essential disulfide bonds, leaving three cysteines as
free reactive thiols. These three cysteine residues have been removed to provide a Cys null
backbone for use in our overexpression studies [119, 120] in order to allow for the
systematic introduction of single cysteines in crosslinking/MS studies.
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Fig. 1: Structure of GlyR (a) Side view and (c) top view crystal structure of
zebrafish α3-GlyR bound to strychnine with extracellular domain at the top [112].
The interface between neighboring units of the pentamer is shown to be bound to
strychnine (green) in (a). (b) Schematic of single subunit of human α1-GlyR. With
sites of mutated single cysteines added at positions 41 and 419 shown in yellow.
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2.2.2 Crosslinking Coupled with Mass Spectrometry (CX-MS)
Numerous experimental techniques including X-ray crystallography, NMR, cryo-EM and
computational methods such as homology modeling are being used to determine the
structure of membrane proteins. Although the above mentioned methods provide a plethora
of invaluable information on the structure of membrane proteins they are not without
limitations. X-ray crystallographic technique provides information on static images of
protein often crystallized after stabilizing the protein in a single state. This is often
accomplished by truncating the more flexible regions of the protein and using antibodies
to covalently bond to the protein thereby stabilizing it. As a result, most of crystal structures
obtained are ligand bound and often do not represent full length proteins that are being
studied [57, 60]. Although NMR can be used to study the flexible regions of the protein
the technique is efficient for small to medium sized proteins, in large proteins spectral
overlap takes place resulting in unstable data collection. Cryo-EM can be a powerful
technique to obtain structural information of membrane proteins in its native state but is a
very time consuming process and often requires x-ray or NMR to further support the data
[121] (refer to chapter 1 for a more detailed description of these techniques). Homology
modeling is a method of using the structural coordinates of a similar protein obtained from
one of the above methods to model the structure of a protein whose structure is yet to be
determined. While this method helps to perform various other studies like docking to
identify drug targets, the model does not accurately represent the structure of the protein.
Recent advances in MS makes it a great structural tool to probe into 3-D structures of
membrane proteins. The distance constraints obtained from the MS studies can be used to
model/refine the structures of proteins whose structures are yet to be determined. This can
help provide a more accurate model for drug target studies resulting in minimal side effects.
Chemical crosslinking techniques combined with high resolution mass
spectrometric methods (CX-MS) have the potential to provide structural characterization
of membrane proteins like GlyR [122, 123]. CX-MS is emerging as a promising technique
to provide structural information of membrane proteins in its native state with a potential
to capture the movements of the flexible regions and require low amounts of sample. CXMS can be used as a complimentary technique other structural techniques such as X-ray,
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NMR and cryo-EM and provide distance constraints that can be used to model/ refine the
structures of membrane proteins. Structural information on the resting state of the
membrane proteins can be obtained using CX-MS technique. One such example of
structural information determined by chemical crosslinking coupled with MS is DMS
induced lysine-lysine crosslinking on GlyBP. A MALDI ionization coupled with bottom
up approach is used in this publication to aid in model refinement of extracellular domain
(ECD) of GlyBP [88, 102]. Chemical crosslinking is the covalent bond formation between
a bifunctional crosslinking agent and the residue within the crosslinking distance in the
protein of interest. A thiol reactive heterotrifunctional crosslinker, that also contains a
photoactivatable group, can chemically target single Cys point mutations. The
benzophenone portion of the reagent is photoreactive and is relatively non-specific; thereby
after disulfide linkage to Cys, photoactivation of the crosslinker will yield random
attachments to neighboring protein backbone giving rise to either intra- or inter- subunit
linkages. This interrogation of the protein landscape around the introduced Cys will allow
for the measurement of both the accessibility of particular residues as well as their distance
[124]. Mass spectrometric analysis of these crosslinked fragments can give the distance
constraint of the cysteine to the fragment of GlyR.
The development of a bottom-up approach of GlyR identification and
characterization using mass spectrometric analysis may provide an invaluable tool to obtain
distance constraints between the residues in GlyR [125]. The electrospray ionization-time
of flight-mass spectrometry fitted with a chipcube (chip-nESI-TOF-MS) will be used to
analyze the intra and inter subunit fragments of GlyR [126] (Fig. 2). By making use of the
high mass accuracy (5-20 ppm) and better mass resolution (>20,000) of the ESI-QTOFMS, the identified crosslinked peptides can be further subjected to MS/MS analysis by
collision induced dissociation in a collision cell to allow for the identification of the amino
acid that is crosslinked [127].
In this study GlyR, a pLGIC is overexpressed in Sf-9 insect cells using baculovirus
expression system after the addition of single cysteines at sites 41 and 419 in Cys null GlyR
in pFastBac plasmid. The protein is then purified using 2-aminostrychnine resin (in house
made) and is reconstituted in lipid vesicles. The purified GlyR is crosslinked with a hetero
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trifunctional chemical crosslinker using radiation with UV. Once the inter- and intrasubunit crosslinks are separated on SDS-PAGE, the bottom up MS analysis is performed
followed by targeted MS/MS analysis to identify the site of crosslinking. The data obtained
will generate distance information of residues within the crosslinker distance. This study
on the resting state of human α1-GlyR will help model the structure of GlyR in its resting
(non-conducting) state (Fig. 2).
2.3. Methods
2.3.1 Polymerase Chain Reaction (PCR)
Mutations were introduced using Quick-change site-directed mutagenesis kit (Stratagene)
to make mutations in Cys null α1-GlyR in pFastBac plasmid following the manufacturer’s
protocol. Briefly, forward and reverse primers containing the desired mutation were
designed and purchased from Eurofins. A typical PCR reaction consists of the addition of
plasmid, forward and backward primers, reaction buffer, dNTP’s and sterile water to make
the sample to 50 µL and Turbo AD DNA polymerase to initiate the reaction. The negative
control lacks the DNA polymerase in the reaction. The PCR reaction is then carried out in
a thermo cycler and the program is set according to the published protocols [128] (Table
1&2).

The formula used to calculate the amount of primer is as follows:

𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑝𝑟𝑖𝑚𝑒𝑟 = 125𝑛𝑔 𝑋

1𝑔
𝑚𝑜𝑙
𝐿
1𝑥106 𝜇𝐿
𝑋
𝑋
𝑋
1𝑥109 𝑛𝑔 𝑀𝑜𝑙. 𝑊𝑡. 10𝑥10−6 𝑚𝑜𝑙
1𝐿
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Fig. 2: Pictorial representation of chemical crosslinking and mass spectrometry
to map 3D-protein structure.
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PCR Program
Step 1
95°C for 30 Sec
Step 2
95°C for 30 Sec
Step 3
55°C for 1 min
Step 4
68°C for 7 min
Step 5
GoTo Step2, 16 times
Step 6
4°C forver
Step 7
END
PCR Reaction
5 µL
10X reaction Buffer
2 µL
Plasmid
~1.25 µL forward primer
~1.25 µL backward primer
1 µL
dNTPs
39.5 µL DI.H2O
1 µL
turbo AD (DNA polymerase)
Table: 1 Table showing the PCR program in a
thermocycler and PCR reaction conditions for
site directed mutagenesis. The amounts for
forward primer and backward primer are
calculated using a formula and 10 µM
concentration sub stocks of primers are used.

The primers were designed such that the melting temperature (Tm) was 52°C- 65°C. The
primer sequences designed are listed below.
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Seq. Name
Sequence 5' - 3'
F207A
CACTACAACACAGGTAAAGCCACCTGCATTGAGGCCCGG
F207A-r
CCGGGCCTCAATGCAGGTGGCTTTACCTGTGTTGTAGTG
A288G
GCCATTGACATTTGGATGGGAGTTTGCCTGCTCTTTGTG
A288G-r CACAAAGAGCAGGCAAACTCCCATCCAAATGTCAATGGC
A41C
CCAGTGAACGTGAGCTGCAACATTTTCATCAAC
A41C-r
GTTGATGAAAATGTTGCAGCTCACGTTCACTGG
H419C
CGTAGAGAGGACGTCTGCAACCAGTGAAGG
H419C-r
CCTTCACTGGTTGCAGACGTCCTCTCTACG
Table 2: Table showing the designed primer sequences (forward and backward) for site
directed mutagenesis. The underlined codons represent the amino acid change to a
cysteine.

2.3.2 Digestion and Transformation of Polymerase Chain Reaction (PCR) Product
The PCR product contains the mutated plasmid, but also unmutated, methylated parental
DNA. Therefore, 1 µL of Dpn-1 enzyme is added to 50 µL of the PCR product to digest
the parental methylated pFastbac plasmid at 37°C for 1 hr. A transformation reaction is
carried out where 1 µL of Dpn digested samples are transformed into 50 µL of XL-1 blue
supercompetent cells by heat shock treatment at 42°C for 45 sec that allows for the new
genetic information to pass into the cells. The cells are allowed to recover by incubating in
NZY+ broth while shaking for an hour at 37°C. The cells are then plated on LB (Luria
Bertani) agar plates containing the antibiotic 50µg/mL ampicillin and are incubated at 37°C
for a day. The single colonies that are grown on plates containing recombinant plasmid are
picked under sterile conditions and are grown in 2 mL liquid LB cultures overnight at 37°C.
This allows the cells to proliferate and increase the amount of mutant DNA in each sample.
The Bio-Rad mini prep kit is used to purify the plasmid and the presence of mutation is
confirmed by sequencing (GENEWIZ) [128].
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2.3.3 Baculovirus Expression of mutant GlyR
The purified mutated pFastbac construct is transformed into MAX Efficiency DH10Bac™
competent cells by heat shock treatment for 1 min 45 sec at 42°C, and then grown in Super
Optimal broth with Catabolite repression (S.O.C) media by incubating it at 37°C for 4h.
100 µl of serial dilutions of 10-1, 10-2, 10-3 samples are plated on Luria agar plates
containing kanamycin (50 µg/mL), tetracycline (10 µg/mL), and gentamycin (7 µg/mL),
Bluo-gal (300 µg/mL) and IPTG (40 µg/mL) and are incubated for 24 to 48h at 37°C. The
presence of white colonies amidst the blue colonies indicates the presence of recombinant
bacmid DNA. The untransformed plasmids contain lac-z operon that can cleave bluo-gal
that is present on the plates giving the blue color to the plates. The recombinant bacmid
DNA interrupts the lacZ operon. Therefore, the recombinant bacmid DNA cannot cleave
bluo-gal. White colonies are picked and are grown in LB media containing antibiotics at
37°C for 24h and the recombinant bacmid DNA is isolated through a series of steps by
using various reagents. The isolated bacmid DNA is then be stored in 40 µl TE buffer at
4°C. This recombinant DNA (1-2 µg) is then transfected into Sf-9 (Spodoptera frugiperda)
insect cells (cell density at 5 x 105 cells/mL) using 6 µL of CellFectin reagent and 100µL
of SFM II media with antibiotics (penstrep 0.5X) in a 6-well plate and is allowed to grow
for 1hr at 28°C. The supernatant is then replaced with SFM II media without antibiotics
and is grown for 72 hr at 28°C. The supernatant containing the virus with mutant DNA
clarified and is saved at 4°C. The viral particles will further be used to infect cells in higher
quantities for the over expression of the mutated protein [129].
2.3.4 Viral Titer Assay
A viral titer assay is performed to identify the plaque forming units per mL (pfu/mL) which
will allow us to calculate the volume of virus to infect the insect cells for overexpression
with a multiplicity of infection (MOI) of 5. 2 mL of 1x106 cells are seeded into 2 6-well
plates. The cells are allowed to attach for 1 hr at 28°C. 10-2 (990 µL Graces media + 10 µL
of virus), 10-4 (990 µL Graces media + 10 µL of virus), 10-5 (900 µL Graces media + 100
µL of virus), 10-6 (900 µL Graces media + 100 µL of virus) and 10-7 (900 µL Graces media
+ 100 µL of virus) dilutions of the virus is prepared. The supernatant is replaced with 100
µL of virus in the 6-well plates and is incubated for 24 hrs at 28°C. Each dilution virus is
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added in duplicate wells. On day 2, the wells are washed twice with 1X PBS buffer and the
cells are fixed with 2 mL of 3.7% formaldehyde for 20 min followed by washing the wells
twice with 1X PBS. The cells are then blocked with 1% gelatin (made in 1x TBS-T)
followed by washing the wells twice with 1X TBS-T. 1 mL primary antibody of anti-gp64
(1:10,000 dilution) (Abcam) is added to each well and is incubated for 1 hr. The wells are
then washed twice with 1X TBS-T. 1 mL of secondary antibody (anti-mouse βgalactosidase conjugate) (Calbiochem) at 1:100 dilution is added to the wells followed by
2 washes with 1X TBS-T. 2 mL Substrate concoction (60 µL X-Gal (50 mg/mL in 100%
DMF) + 60 µL NBT (83 mg/mL in 70% DMF) + 5mM MgCl2) is added and the wells are
incubated for 45 min in dark. The cells stained blue are counted under microscope. The
number of cells per dilution are counted and the average pfu/mL is calculated.
𝑝𝑓𝑢
1
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑣𝑖𝑟𝑢𝑠 = 𝑚𝐿 𝑋
𝑀𝑂𝐼
𝑛𝑜. 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠

The volume of virus is calculated using the formula with a MOI of 5 will be used to infect
the insect cells in large quantities for overexpression of recombinant GlyR.
2.3.5 Overexpression of mutant GlyR Protein
Once the presence of GlyR is verified using Western blot assay, the saved supernatant is
added to a spinner flask (volume determined based on multiplicity of infection (MOI)=5)
containing about 600 mL of cells at a concentration of about 1x106 cells/mL and +97%
viability. After three-day incubation, the cells are harvested by centrifugation followed by
testing the pellet and supernatant using Western blot assay for the presence of mutant GlyR
[129].
2.3.6 Purify and concentrate mutant GlyR protein
In order to purify the mutant protein conditions used in [120] were adapted. Briefly, the
above obtained mutant cell pellet is re-suspended and washed three times in an isotonic
phosphate buffered saline solution. The cells are then suspended in a hypotonic solution
containing 5 mM Tris (pH 8.0), 5 mM EDTA, 5 mM EGTA, 10 mM dithiothreitol, for 1 h
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at 4 °C to swell the cells prior to lysing. Anti-proteolytic cocktail containing 16
milliunits/ml aprotinin, l µM benzamidine, l µM phenylmethylsulfonyl fluoride, and 1 µM
benzethonium chloride are added to the cells to prevent denaturing of the proteins. The
solution is then sonicated using a probe tip sonicator with micro tip attachment to lyse the
cells. The lysed cell solution is then centrifuged using a Beckman Type 70.1Ti
ultracentrifuge rotor at 65,000rpm for 30 minutes to produce a pellet consisting of both
integral and peripheral membrane proteins. The pellet is then re-suspended in a hypertonic
saline solution (hypotonic solution +300mM NaCl) that removes the non-covalently
bonded peripheral proteins from the cell membranes, sonicated to ensure complete cell
lysing, and centrifuged as previous. The resulting pellet is re-suspended for 48hours in a
1% digitonin and 1% deoxycholate solution for the purpose of solubilizing the integral
membrane proteins followed by the addition of dithiothreitol (DTT) to prevent disulfide
bonds from forming between cysteine residues. This solution is centrifuged at 65,000 rpm
to separate the solubilized membrane proteins. The supernatant, consisting now of only
integral proteins, is added to 2-aminostrychnine agarose resin and left to incubate for 24
hours under constant nutation. Strychnine is a high-affinity competitive antagonist of GlyR
(Kd in the nano molar range), thus, the GlyR in solution will bond to the strychnine coated
agarose resin, and while the other membrane proteins will remain in solution. A 200mM
strychnine elution buffer is added to the GlyR containing resin and allowed to nutate for
40hours. The concentration of strychnine is high enough in solution (1.5mM) to compete
with strychnine and eventually the GlyR completely unbinds from strychnine. This solution
is lightly centrifuged and the supernatant containing purified GlyR is removed. The
purified GlyR obtained is reconstituted in a combination of phosphotidyl cholines (PCs)
and cholesterol and is concentrated in 25mM potassium phosphate buffer via dialysis. Once
the dialysis is complete, the GlyR solution is sonicated in the presence of lipids and is
centrifuged at 65,000 rpm to produce a pellet, which is then re-suspended in 1mL of 25mM
potassium phosphate buffer in order to determine concentration of the purified protein.
2.3.7 Western Blot Assay
Samples for SDS-PAGE gel are prepared from the cells in the well plate and Western
blotting is performed in order to confirm the presence of GlyR protein production in the
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cells. BSA (Bovine Serum Albumin) is used as a negative control and WT GlyR stock is
used as a positive control for SDS-PAGE. The gel obtained from the SDS-PAGE is
transferred on to nitrocellulose membrane by Western blotting. The membrane is placed in
a blocking buffer to avoid any non-specific binding of the protein. 2 µL of primary antibody
with 1:25,000 in 10 mL 1X PBS (rabbit anti-GlyR) (abcam) followed by a 2 µL of
fluorescent secondary antibody 1:1000 in 1X PBS (goat anti-rabbit) (Li-cor) is added to
the membrane for more specific binding of the protein thereby for a better signal. The
membrane is washed thrice with liberal amounts of 1X PBS-T between the additions of
antibodies. The membrane is visualized using ODYSSEY infrared imager. The band
obtained at 49 kDa confirms the expression of protein from the mutated DNA.
2.3.8 Modified Lowry Assay
Following purification, a modified Lowry assay, was used to determine the concentration
of GlyR. The modified assay procedure is designed to allow for determination of protein
concentration in the presence of detergent or phospholipid, which may interfere in a
standard Lowry assay [130]. A 10 μL and 100 μL aliquot of the purified GlyR in potassium
phosphate buffer is diluted to 1mL with deionized water. In addition to the GlyR, several
standards of bovine serum albumin (BSA) are also diluted to 1mL with deionized water at
varying concentrations from 1-20 μg/mL to plot a calibration curve. To the diluted protein,
0.15 mL of 1% deoxycholate is added and allowed to sit for 10 minutes prior to adding 0.1
mL of 72% trichloroacetic acid (TCA). Deoxycholate naturally precipitates in the presence
of the stronger TCA, and when added to the protein mixture, acts as a co-precipitant by
hydrophobically binding to the protein, helping to ensure that all of the protein precipitates
in the presence of TCA. The protein precipitate needs to be centrifuged at 3,000xg for 10
minutes and the supernatant carefully aspirated. To the precipitate, 0.2 mL of deionized
water and 1 mL of modified Lowry reagent is added. The sample vials are thoroughly
mixed and allowed to incubate for 10 minutes. Finally, 0.1 mL of 1:1 Folin-Ciocalteu
phenol reagent: deionized water is added, mixed, and allowed to incubate for 30 minutes.
Appearance of faint blue color represents the presence of protein. The absorbance is read
using a UV/VIS spectrophotometer at a wavelength of 750 nm and the concentration of
GlyR was determined with the help of BSA calibration curve [131].
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2.3.9 Crosslinking of mutant GlyR with MTS-Benzophenone
250 µL aliquot of the mutated GlyR sample in phosphate buffer and the crosslinker MTSbenzophenone (1.9 mg/mL in DMSO) is taken in 1:5 ratios and allowed to react overnight
on a nutator in the dark so that the sulfhydryl group in MTS reacts with the sulfhydryl of
the cysteine in the mutant GlyR. The sample is placed into a quartz cuvette and is exposed
to a UV light source for 20 minutes on ice to prevent protein denaturation due to heat. 20
µL crosslinked samples without 1mM DTT are then loaded onto a on 15% SDS-PAGE in
order to separate inter-subunit crosslinks (high mass) from intra-subunit crosslinks (low
mass) With the help of BSA (78kDa) as a molecular weight marker, gel plugs of intersubunit and intra-subunit crosslinks are excised and are subjected to in-gel trypsin
digestion.
2.3.10 Trypsin digestion of gel plugs
An in-gel trypsin digest is performed to cleave the protein after arginine or lysine residues.
The gel plugs are initially washed with 50:50 methanol: 50mM ammonium bicarbonate
solution and then dried with acetonitrile. The gel plugs are then reduced using 10 mM DTT
and are alkylated using 50 mM iodoacetamide (IAA). The gel plugs are then soaked in
buffer containing trypsin gold (Promega) for 24 hours at 37°C. The protein is then extracted
from the gel plug and the solvent is evaporated, leaving only the purified, trypsin-digested
protein. The trypsin is able to completely digest the GlyR subunits as the globular structure
is lost in the denaturing SDS-PAGE gel.
2.3.11 Sample preparation for MS analysis
Sample preparation for MS analysis is an important step in the process of detection of
peptic fragments using mass spectrometry. Zip Tips are 10 µL pipette tips that contain very
small, reverse-phase C18 columns. These Zip Tips are calibrated using 50% ACN three
times and then 0.1% formic acid solution three times. The digested peptide sample is resuspended in 10 µL of solution containing 0.1% formic acid in Milli-Q® water. The above
sample is then pipetted through the column 10-20 times to allow the peptides in the sample
to bind to the column. The column is then washed with 0.1% formic acid solution to remove
any impurities and the peptides bound to the column will finally be eluted using 10µL of
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0.1% formic acid in 50% methanol. The purified sample is now concentrated and is ready
for electro-spray ionization MS analysis.
2.3.12 MS analysis of the peptic fragment samples of mutant GlyR
Agilent nano-electrospray ionization time-of-flight mass spectrometer fitted with chipcube
(G4240A) (chip-nESI-QTOF-MS (G6530B)) is used to analyze the crosslinked, tryptic
digested peptide fragments of mutant GlyR [132]. The ESI-QTOF-MS is fitted with a chip
cube to facilitate nanospray ionization. The sample is re-suspending in 40 μL of 0.1%
formic acid in water and is run using a developed and optimized 11min method. Once the
sample is run, qualitative analysis software (Agilent) is use to data analyze and identify
crosslinked peptides within 10 ppm mass difference. The identified crosslinked fragments
are rerun on the instrument with a targeted list of m/z to get a fragmentation pattern of each
crosslinked peptide which will enable us to identify the site of crosslinking. Data analysis
is performed using software including Masshunter qualitative analysis (Agilent),
prospector (MS-product UCSF), SkyLine (MACCOSS LABS), Spectrum Mill (Agilent)
and Mass hunter (Agilent). Analyses thus provide distance constraints (the length of the
linker) between the site of attachment (the introduced single Cys) and the photoproducts.
This information will help us to validate and refine the resting state model of GlyR using
global ensemble-based energy restraint methodology [133, 134].
2.4. Results and Discussion
2.4.1 Overexpression and purification of Cys null A41C and H419C human α1-GlyR
Single Cys are added at positions 41 where an alanine is mutated to Cysteine and at position
419 where a histidine is mutated to cysteine in Cys null human α1-GlyR, respectively. The
mutated GlyR samples are then overexpressed in Sf-9 insect cells using baculovirus
expression system. The viral titers and concentrations determined by modified Lowry assay
of the mutant protein samples are listed in Table 3. The mutations made are then
characterized for function (Fig. 3).
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Table 3: Table showing the concentrations of mutant
GlyR sample titers and concentrations. The listed
concentrations are calculated based on 3 purifications of
each GlyR sample. P<0.05

Fig. 3: Whole cell patch clamp studies of A41C GlyR mutant:
Response of A41C GlyR mutant in Sf-9 cells to a saturating
[Glycine]. X-axis shows time in seconds and current (nA) on y-axis.
Whole cell patch clamping Studies performed by Dr. Shawn
Kotermanski to characterize mutant GlyR
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2.4.2 MS analysis of Cys null A41C and Cys null H419C human α1-GlyR to identify
the peptides that are within crosslinker distance in the resting state of human
α1-GlyR

The crosslinker MTS-benzophenone (Fig. 4) consists of three portions: the MTS portion
that binds to the sulfhydryl group of cysteine (Fig.5), the benzophenone portion that nonspecifically reacts to the backbone of the protein upon photo activation (Fig.6) and the
alkyne portion that can be biotinylated using click chemistry. The UV exposure activates
a radical reaction at the benzophenone that randomly attacks the backbone of the protein
either within the same subunit or across adjacent subunits and forms a covalent linkage.
Also, because of the non-specific binding of the crosslinker, it may bind to a molecule in
the solvent and become irrelevant to the distance studies. Each GlyR pentamer contains at
most five crosslinks, attached via disulfide linkage in each subunit, but likely fewer than
five will exist.
A SDS-PAGE separation in the absence of reductant is performed on the UVexposed crosslinked mutant GlyR with BSA and wild type GlyR as controls in order to
separate the oligomeric and monomeric fragments of mutant GlyR. Sodium dodecyl sulfate
(SDS) allows for the unfolding of the protein in the presence of polyacrylamide gel. The
gel is then stained with Coomassie blue dye. BSA band is then identified, which is about
66,000 Da, and this weight is considered to be between the weights of the crosslinked
oligomers (potentially containing inter-subunit crosslinks) more than 97,000 Da and the
crosslinked monomers (intra-subunit crosslinks) 48,500 Da. The portions of the gel that lie
above and below the position of the stained BSA, corresponding to each of the samples,
are excised resulting in gel plugs containing both intra/inter-subunit (oligomeric)
crosslinked protein and only intra-subunit (monomeric) crosslinked protein for each
sample.
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Fig. 4: Structure of the crosslinker highlighting the sites of reaction in red. The
brackets indicate that the length of the crosslinker can be varied based on requirement

Fig. 5: Pictorial representation of the reaction of MTS portion of MTS benzophenone
with the sulfhydryl group of cysteine in the mutant GlyR protein
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Fig. 6: Pictorial representation of the benzophenone portion of the MTS-reagent reacting
with the protein backbone to form a complex.

The mass shifted peaks corresponding to the crosslinked peptides were identified
after MS analysis (Fig. 8) and analyzed using Agilent Qualitative analysis software (Fig. 9
& 10). The identified crosslinked peptides in both oligomeric and monomeric fractions of
each GlyR mutant are listed below (Table 4 & 5).

2.4.3 MS/MS analysis of Cys null A41C and Cys null H419C human α1-GlyR to
identify/refine the site of crosslinking on the peptide
The identified mass shifted peaks corresponding to the crosslinked peptides are targeted
and further fragmented using collision induced dissociation (CID) method to identify the
residue that is crosslinked in the peptide. A representative MS and MS/MS spectra of Cys
null A41C showing the identified site of crosslinking shown Fig. 7. The residue/residues
that the crosslinker bound to are identified for the resting state of oligomeric and
monomeric Cys null A41C and Cys null H419C GlyR in the Table 6&7 below.
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Table 4: Table showing the identified mass shifted
tryptic peptides extracted from monomeric and
oligomeric bands in SDS-PAGE of Cys null A41C.
All sample sets were run in triplicate (n=3) and
peptides identified reproducibly within 10ppm
mass difference. Common crosslinks between
mono- and oligomeric fragments are assumed to be
intersubunit crosslinks and are grayed out, and
unique oligomeric mass shifted tryptic peptides are
assigned as intersubunit crosslinks and are
highlighted in green.
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Table 5: Table showing the identified mass shifted
tryptic peptides extracted from monomeric and
oligomeric bands in SDS-PAGE of Cys null
A419C. All sample sets were run in triplicate (n=3)
and peptides identified reproducibly within 10ppm
mass difference. Common crosslinks between
mono- and oligomeric fragments are assumed to be
intersubunit crosslinks and are grayed out.
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Fig. 7: Representative MS (top) and MS/MS Spectra (bottom) of cross-linked A41C in apo state. Identified fragmentation pattern in
collision induced dissociation (CID) is shown with assigned b and y ions

Mass spectrometric method
Instrument
6530 accurate qTOF MS
C18 reverse column
(75µmX150mm seperation
Column
column & 40nL enrichment
column)
Injection Volume 2µL
Run time
11min
Flow
Gradient
A: 95%water;5%ACN;0.1%FA
Solvents
B: 95%ACN;5%water;0.1%FA
0 min - 95% A; 5% B
7 min - 40% A; 60% B
Method
9 min - 10% A; 90% B
9.10 min - 95% A; 5% B
200-1700 mass range
Parameters
175V fragmentor voltage
Xlinker Massshift
311.3838
+H+ (+1.007),+Na+ (22.989), +K+
(38.963), Alkylation (+57.0522),
Species
Oxidation (+15.99405), Acryl
(+174.0462)
Error
MS- 10ppm MS/MS- 0.1Da
Mass hunter;
Software
UCSF prospector
Collision induced dissociation
Targeted MS/MS
(CID)
Collision energy
slope (3.7)Xm/z/100+offset(2.5)
4 precursors/cycle sort by charge
state then abundance purity
MS/MS parameters
stringency-100% purity cutoff30%
Fig. 8: Details of the method set up and parameters developed
and optimized in MS and MS/MS analysis
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Table 6: Table showing the identified crosslinked peptides using CID within 0.1Da in Cys null
A41C. Unique mass shifted peptides identified solely in the higher-MW extracted peptides are
highlighted in green and are assigned as intersubunit crosslinks. The residue/short peptides
identified in MS/MS studies as the sites(s) of crosslinker attachment to are highlighted in pink.

Fig. 9: Figure showing the identified inter- and intrasubunit crosslinks in Cys null A41C (41C highlighted in
yellow). Identified sites of crosslinking are highlighted in
blue. For clarity of viewing, two non-adjacent α1
subunits are shown.
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Table 7: Table showing identified crosslinked peptides using CID within 0.1Da
in Cys null H419C. The residue/short peptides identified in MS/MS studies as the
sites(s) of crosslinker attachment to are highlighted in pink.

Fig. 10: Figure showing the identified inter- and intra-subunit crosslinks in Cys null
A419C (419C highlighted in yellow). Identified sites of crosslinking are highlighted in
blue. For clarity of viewing, two non-adjacent α1 subunits are shown. No unique
intersubunit crosslinks are observed at 419C site in resting state of hGlyR.
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The Cα-Cα distance of the MTS-benzophenone crosslinker used in these studies
covalently bound to protein backbone is approximately 25Å. In examining the identified
crosslink sites in our model of GlyR, all the identified sites are within are within this 25Å
distance. Thus the distance constraints obtained are consistent with the available structures
of GlyR. Significantly, the sites of crosslinking are all observed in the extra-cellular domain
(ECD) as expected and no crosslinking events were identified in the transmembrane helices
or the intracellular domain that are inaccessible from the ECD (and these regions comprise
~50% of the mass of the protein), thus giving us confidence in our data and strongly
suggesting the successful application of the mass spectrometric method coupled with
crosslinking to study the structure of α1-GlyR in its resting state. All the mass
spectrometric runs are carried out in triplicate and the identified crosslinked sites listed are
observed in more than one ion species (protonated, sodiated, potassiated, alkylated and
oxidated species). The utility of using a photoactivated crosslinker can be observed by the
multiplicity of crosslinking events, as we identified at least 15 sites of crosslinking for each
single Cys mutant. The promiscuity of binding events provides a large number of distance
constraints that can then be used to validate and refine structural models. While the
introduction of the 2 mutations presented here, while consistent with our homology model
of the receptor, cannot rigorously validate the model, we propose that a network of
systematically introduced single Cys mutants will allow us to further refine the structure
of human GlyR.

For our studies, milligram quantities of the GlyR is crosslinked and microgram
quantities of the crosslinked sample is loaded on to the SDS-PAGE for in-gel trypsin
digestion. The eluted sample after proteolysis contains nanogram quantities of protein
sample. The sample is then concentrated and a 1/10th of this sample volume is injected
into the electrospray ion source for MS analysis. This suggests that nanogram (~100ng)
quantities of the protein samples can give detectable signal to identify the sites of
crosslinking illustrating the sensitivity of high resolution mass spectrometry (HRMS).
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2.5. Conclusions
CX-MS identified unique intra- and inter-subunit crosslinked peptides in the resting state
of A41C and H419C GlyR (in Cys null background). MS/MS data for all mass-shifted
peptides further refined the sites of crosslinking and provided distance restraints. 419C is
present in the extracellular C-terminal tail, a potentially flexible region that is absent or
unresolved in all pLGIC structures to date. MS/MS data conducted on mass-shifted
crosslinked peptides identified a single site of crosslinking or refined the site of
crosslinking to a few residues within the mass shifted tryptic fragment. Most of the sites
identified are in the ECD suggesting that the C-terminus extends out and far from the lipid
membrane and is closer to the regions of ECD. Further investigation needs to be carried
out with studies of Cys at other accessible sites in ECD and usage variable length
crosslinker to determine the distance of C-terminus loop to the ECD. The Distance
constraints obtained from CX-MS studies at site 419 shows the utility of CX-MS to provide
structural information for poorly resolved regions in homology models. The mutation at
position 41 was selected as it is an endogenous Cys site in the wild type receptor (it was
mutated to create the Cys null construct) is known to be accessible from previous studies
and is close to the pre M1 loop believed to undergo conformational changes during channel
gating and desensitization. The sites of crosslinking identified in MS/MS studies identified
many sites that are intra subunit (within the subunit) crosslinks and a couple sites that are
inter-subunit (between two subunits) crosslinks. Sites 128-131 and 414 of neighboring
subunit are within the crosslinker distance of 41 site. Although common mass-shifted
tryptic peptides have been identified as being crosslinked in both 41C and 419C studies,
MS/MS studies identified unique sites of covalent attachment with the mass shifted
peptide. For example, the 3-20 peptide is targeted in both 41C and 419C crosslinking
studies conducted in the resting state. But MS/MS studies showed that the sites of
crosslinking from 41C are between residues 7-14 and 419C studies crosslinked to residue
20, suggesting that the method is capable of detecting the distance constraints at a residue
level. Crosslinking to an amino acid within position 34-36 is uniquely identified in
crosslinking studies from 419C but is absent in 41C studies. These studies show that CXMS is able to identify sites of covalent attachment within identified mass-shifted tryptic
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peptides, and thus may be capable of identifying networks of crosslinks that will aid in
modeling/refining the resting state structure of human α1-GlyR.

Future work will apply CX-MS to systematically introduced single cysteines in
GlyR, to generate a more comprehensive matrix of distance constraints in resting state as
well as in other functional states of human α1-GlyR (state-dependent crosslinking is
presented in the next chapter). This information will be used to update and refine the
models of GlyR in its different conformational states. This approach is particularly useful
in identifying networks of constraints for flexible loops that may be poorly resolved in
structural homologs. Further work will focus on quantitating the frequency of crosslinking
using amine-reactive NDA and/or fluorescent tagging of the alkyne tag present on the
crosslinker and subsequent laser induced fluorescence on microfluidic platform developed
in the lab (Davic, PhD thesis, 2016).
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CHAPTER 3
Human α1-Glycine Receptor Allostery as Identified by State-dependent
Crosslinking Studies
3.1 Introduction
GlyR is a member of the pentameric ligand gated ion channel superfamily. High resolution
structures of many of these ion channels have been determined including open structure of
TMD of human α1-GlyR using NMR, human α3-GlyR bound to strychnine using X-ray
crystallography and zebrafish α1-GlyR using cryo-EM [112, 113]. However, information
regarding receptor allostery and the more flexible loops of these channels are less well
known [66, 111-113]. hGlyR is implicated in various neurological disorders like
hyperekplexia and chronic pain [114, 115] and is shown to be a target for anesthetics and
alcohols [116]. GlyR exhibits predominantly three states: resting, open (msec) and
desensitized (sec). To better understand the structure and function of GlyR in its different
states, crosslinking/mass spectrometry (CX-MS) studies have been conducted.

As

described in previous chapters, this method has the capability of providing molecular
information of receptor allostery, requires relatively low protein concentrations (pmol).
F207A/A288G mutations in human α1-GlyR alter the ligand sensitivity and stabilize
the GlyR in a non-desensitizing state in the presence of ivermectin [135, 136]. To better
understand the structure and function of GlyR in its different states, crosslinking/mass
spectrometry (CX MS) studies have been conducted in this background. Individual
cysteines are added at positions 41 and 419 into Cys null or Cys null F207A/A288G
background (referred to as IVM-sensitive) and MTS-benzophenone with an alkyne tag is
used as a crosslinker. The crosslinker forms a disulfide bond with the cysteine residue in
the mutant GlyR upon incubation and the benzophenone portion of the crosslinker photo
crosslinks with the neighboring accessible backbone portion of the protein within the
crosslinker distance in a state-dependent manner when activated by UV light. The
crosslinked protein is then in-gel trypsin digested and the eluted fragments analyzed using
ESI QTOF MS/MS to identify the mass shifted peptides that contain the added mass of the
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crosslinkers. Analyses of CID patterns from daughter ions in MS/MS scans allow
determination of regions within the tryptic fragment that contain the site of covalent
attachment, with these studies often being able to identify sites of attachment at single
amino acids. Unique sites of crosslinking specific to each conformational state of GlyR are
identified and will be used to refine the structural models and provide insight into receptor
allostery.
3.2 Background
3.2.1 Glycine receptor (GlyR)
Glycine receptors (GlyRs) are inhibitory ligand-gated receptors that belong to nicotinicoid
receptor superfamily. GlyRs mediate neurotransmission in CNS and are typically activated
by glycine. Inhibitory members of the nicotinicoid receptor family, also known as the Cysloop family of ligand-gated ion channels such as GlyR, glutamate gated chloride channel
receptors (GluCIRs) and GABA type-A receptors show promising silencing activity as
these chloride channels typically allow passive influx of Cl-, further hyperpolarizing the
cell under typical conditions [111, 114]. The receptors in this family are pentamers
arranged in a ring around a central ion-conducting pore. Each subunit consists of an
extracellular N-terminal ligand-binding domain (ECD), four trans membrane helices (M1M4) and a intracellular domain between M3 and M4 [117]. GlyRs are primarily expressed
in spinal cord, brain stem, caudal brain, and retina. GlyR mediates the inhibition of fast
synaptic neuronal transmission. In the absence of a ligand (glycine), the receptor is in a
resting state. Upon glycine binding, the receptor enters into a short-lived open state,
allowing the Cl- ions to pass through the channel and altering the polarizability of the
neurons. The receptor then transitions to a desensitized state of the receptor where the
ligand remains bound but, the channel is in a closed, non-conducting conformation [115].
GlyRs can be composed of a various combinations of α1, α2, α3, α4 and β subunits.
Typically in most of adult humans, it is composed of two α subunits and three β subunits
[118]. However, expression of human α1 subunits is sufficient to reconstitute homomeric
receptors that are native-like in function. Various Cys-loop receptor structures have been
solved in cryo-EM, X-ray crystallographic and NMR studies that provided insight into Cys-
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loop receptor structure [52, 66, 112, 113, 136-138]. However, these methods are often
limited in providing static images and the flexible regions of the protein are often truncated.
The molecular mechanism of hGlyR gating and desensitization still remains to be
deciphered. Elucidating the molecular mechanism of activity can help treat various
neurological disorders like hyperekplexia and chronic pain [114, 115].
3.2.2 Ivermectin (IVM)
IVM was originally identified as an anti-helminthic and was FDA approved to treat
parasitic infections [139]. IVM is a ligand for the related glutamate- gated chloride channel
(GluClR), and potentiates GlyR (Fig. 11). The double mutation F207A/A288G in α1subunits alters the affinity and efficacy of GlyR for IVM. The dose response curves of wild
type (WT) and mutated GlyR in the presence of glycine and IVM showed that
F207A/A288G is sensitively gated by IVM and is more insensitive to glycine. The
threshold of activation of GlyR by IVM (100-300nM) is very high compared to GluCIRs
(1-3nM) [140, 141]. Recombinant GlyR that is IVM sensitive (EC50 = 19nM) and glycine
insensitive (EC50 = 40µM) can be exploited in studies as the non-desensitizing (open)
engineered channel may be selectively activated by external systemic administration of
IVM and can be used to elucidate the structure of GlyR in its conducting state.

3.2.3 Crosslinking with mass spectrometry (CX-MS)
Crosslinking combined with mass spectrometry (CX-MS) and bioinformatics is an
emerging technique to study the structure of membrane protein allostery due to its ability
to study the protein in its physiological state and the need to have less material in
comparison with other available techniques to study the membrane protein structure [101].
The sensitivity and resolution of MS allows investigators to probe and analyze the protein
in detail providing high throughput information on protein structure and organization.
Variable-length crosslinkers can further be used as a ruler in identifying subtle
conformational change in a protein and gives CX-MS advantages over other structural
techniques currently in the field [93].
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Fig. 11: Figures showing the crystal structure of GluCl with IVM bound. a. Top view of the crystal structure of GluCl showing Fab
attached. b. Side view of GluCl structure with IVM and Glutamate bound. c. Mechanism of allosteric activation of GluCl by IVM.
Figure taken from Nature, 2014. 512(7514): p. 333-337 [136]

The protein once stabilized in a given allosteric state is crosslinked and then subjected to
enzymatic digestion. The peptides obtained are then separated by liquid chromatography
and analyzed by MS. MALDI-TOF-MS and ESI-qTOF-MS are the two major techniques
used to study the structure of proteins. Once the crosslinked (mass shifted) peptides are
identified using a database search, they are subjected to targeted MS/MS analysis using
collision induced dissociation (CID) to identify the site of crosslinking. The stringency and
the purity cutoff of the mass-shifted peptides identified provide confidence in the
assignments [142, 143].

These studies will help understand the correlation of GlyR allostery with function
by aiding in development of homology models of resting (no ligand), open (IVM GlyR
with IVM) and desensitized states (Cys null GlyR with Glycine) of α1-hGlyR [135]. Single
cysteine mutants introduced into IVM sensitive and Cys-null GlyR constructs coupled with
crosslinking and mass spectrometry (MS) will allow us to study the structure of GlyR in a
state dependent manner.
3.3 Methods
An overview of the methods used are shown schematically Figs. 12 and 13, and are
identical with methods described in Chapter 2.3 section with the following variations:
1. An IVM sensitive F207A/A288G double mutant was prepared to enable open state
crosslinking studies. Mutations were placed in Cys null background as described in
Chapter 2. Single Cys were introduced at positions 41 and 419 in the IVM sensitive
background. These samples were overexpressed in Sf-9 insect cells using
baculovirus overexpression system as described in Chapter 2 and were purified
using amino-strychnine resin and reconstituted in lipid vesicles.
2. The GlyR samples: 41C and 419C in Cys null background and IVM sensitive
background were stabilized in their three general conformational states before the
samples are crosslinked as follows: Resting state: Cys null GlyR (no ligand), Open
state: IVM sensitive GlyR (F207A/A288G) with 10nM IVM and desensitized state:
Cys null GlyR with 10mM glycine.
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Fig. 12: Pictorial representation CX-MS showing the work flow of the hGlyR sample. Briefly, the
protein sample is stabilized in a conformational state and is crosslinked using UV upon incubation of
the crosslinker. The crosslinked sample is then ran on a SDS-PAGE to separate oligomeric from
monomeric bands and is then in-gel trypsin digested and is subjected to MS analysis. The identified
crosslinked peptide from MS is then targeted to identify the site of crosslinking. The sites of
crosslinking identified are then used to further refine the models of GlyR

Fig. 13: Flowchart of the workflow of the state-dependent crosslinking.
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Fig. 14: Schematic of single α1-hGlyR subunit showing sites of
mutation. The F207A and A288G (green) double mutant converts
the receptor to an IVM sensitive non-desensitizing receptor. Single
cysteine mutations were introduced at positions 41 and 419
(yellow).

3.4 Results and Discussion
3.4.1 Overexpression and characterization of 41 and 419 in Cys null and IVM
sensitive background
A41C and H419C hGlyR in Cys null and IVM sensitive background (See Fig. 14) were
successfully overexpressed, purified, and reconstituted into lipid vesicles. The levels are
measured using modified Lowry assay. The average yield per preparation is provided in
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Table 8. In all cases, our overexpression system was able to produce sufficient quantities
of purified GlyR sufficient for the needs of these studies.

Whole cell patch clamping studies of Sf-9 cells showed that the expressed mutant receptors
retained activity and were gated by glycine and IVM (whole cell patch clamping study
conducted by Dr. Kotermanski) (Fig. 15).

Fig. 15: Whole cell patch clamp studies of IVM A41C GlyR mutant.
Response of IVM A41C GlyR mutant in Sf-9 cells to mM [glycine] and
nM [ivermectin]. Ivermectin activates the IVM-gated double mutant
receptor in a non-desensitizing manner, consistent with reports by other
investigators [135] (Courtesy: Dr. Shawn Kotermanski)
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Table 8: Table showing the concentrations of mutant hGlyR samples purified for
crosslinking studies. Concentrations are in µg and the error is based on samples purified
in triplicate. P< 0.05

3.4.2 MS analysis of human α1-GlyR 41 and 419 in Cys null and IVM sensitive
background

In order to conduct state-dependent crosslinking studies, the purified hGlyR samples were
stabilized in its three predominant conformational states prior to photoactivation: In all
cases, the MTS-benzophenone crosslinker was incubated with GlyR at 1:5 ratio of protein:
MTS-benzophenone as described in Chapter 2. This will ensure the availability of one
crosslinker molecule for each subunit of the pentameric GlyR. The receptor is then
stabilized in the resting (Cys null GlyR with no ligand), open (IVM GlyR with 10nM IVM)
or desensitized state (Cys null GlyR with 10mM Glycine) prior to crosslinking. This will
ensure state dependent crosslinking upon UV activation of the benzophenone moiety, one
of the reactive sites in the crosslinker. Non-specific insertion of the benzophenone is then
induced by photoactivation using broadband UV light. Upon UV activation the
benzophenone active site forms a free radical and attacks its nearest accessible carbonyl
group and covalently gets attached to it forming non-specific crosslinks. The possible intraand inter-subunit crosslinks because of the pentameric symmetry of GlyR are seperated as
described in Chapter 2 by excising the monomeric and oligomeric bands of the GlyR run
on SDS gels and in gel trypsinized, peptide fragments are then extracted from oligomeric
and monomeric gel plugs and subjected to MS analysis using Agilent ESI-qTOF-MS
(Table 9 & 10) (Fig. 16). The obtained mass-shifted crosslinked peptide data gives
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information on the peptides that are within the crosslinker distance from the site of
crosslinking.

Table 9: Table showing the crosslinked peptides identified in the oligomeric and
monomeric fractions of A41C. Common crosslinks between oligomeric and monomeric
fractions are grayed out and the crosslinked peptides unique/absent in other states are
highlighted in pink. *Cys null GlyR only, **IVM GlyR with 10nM IVM, ***Cys null
GlyR with 10mM glycine. Crosslinked peptides identified are within 10ppm of generated
theoretical list.
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Table 10: Table showing the crosslinked peptides identified in the oligomeric and
monomeric fractions of H419C. Common crosslinks between oligomeric and monomeric
fractions are grayed out and the crosslinked peptides unique/absent in other states are
highlighted in pink. *Cys null GlyR only, **IVM GlyR with 10nM IVM, ***Cys null
GlyR with 10mM glycine. Identified peptides are within 10ppm of theoretically
generated list.

Once the mass-shifted peptides are identified in the different conformational states, the
samples are then rerun targeting the mass-shifted crosslinked peptides for MS/MS by CID
to identify/refine the site of crosslinking (Table 11 & 12) (Fig. 17 & 18).
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Fig. 16: Representation of MS (top) and MS/MS Spectra (bottom) of cross-linked
peptide to F207A/A288G (IVM) A41C in open state. Identified fragmentation pattern in
collision induced dissociation (CID) is shown with the b and y ions.
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Table 11: Table showing MS/MS data identifying the site of crosslinking of A41C in the three conformational states of hGlyR.
Cut-off for CID MS/MS data is 0.1Da. The mass shifted crosslinked peptides from initial MS runs are shown in black and the sites
of crosslinking identified are in pink. *Cys null GlyR only, **IVM GlyR with 10nM IVM, ***Cys null GlyR with 10mM glycine
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Table 12: Table showing MS/MS data identifying the site of crosslinking of A419C in the three conformational states of hGlyR.
Cut-off for CID MS/MS data is 0.1Da. The mass-shifted crosslinked peptides from initial MS runs are shown in black and the
sites of crosslinking identified are in pink. *Cys null GlyR only, **IVM GlyR with 10nM IVM, ***Cys null GlyR with 10mM
glycine
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Fig. 17: Figures showing the intra subunit crosslinks (blue), intersubunit crosslinks (cyan) and state dependent unique crosslinks
(orange) in 41 sample. Cys at 41 is shown in yellow. Crosslinks shown for resting, desensitized and open state respectively
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Fig. 18: Figures showing representation of the intra subunit crosslinks (blue), intersubunit crosslinks (cyan) and state
dependent unique crosslinks (orange) in 419 sample. Cys at 419 is shown in yellow. Crosslinks shown for resting,
desensitized and open state respectively. Since no crystal structure has the flexible C-terminal loop. Cysteine at 419 is
shown at top of M4 helix since the C-terminus of pLGICs are not resolved in any crystal structure.

3.5 Conclusions
CX-MS has proved to be an efficient method to reproducibly identify sites of crosslinking
in all the three conformational states of hGlyR. Subtle changes in the conformation of
hGlyR within the crosslinker tethered at positions 41 and 419 were identified. MS/MS
studies of 41C GlyR identified that residues 194-196 are within crosslinker distance to 41C
in the resting and desensitized state but not in the open state. It is interesting to note that
194-196 region is adjacent to loop C region (198-209) that is critical for cell surface
expression and ligand binding [144]. It can be concluded that IVM binding to GlyR is
inducing a conformational change such that these two regions move further apart, rendering
194-196 inaccessible to the tethered crosslinker. MS/MS studies of 419C GlyR identified
amino acids 216-218 to be within crosslinker distance in the resting and open states but not
in the desensitized state. The 216-218 region is located in the pre-M1 region of GlyR and
is believed to undergo an allosteric change. The conformational change due to IVM binding
if any seem to be minimal on the Pre-M1 region while binding of Glycine definitely seem
to induce a conformational change in the pre-M1 region. Identifying and observing the
presence/absence of these two peptides in our studies indicate the conformational changes
in both ECD and pre-M1 region is consistent with the unblooming concept of the receptor
upon ligand binding. Further studies need to be conducted to shed more insight into channel
gating and mechanism of action of hGlyR.

Unique inter-subunit crosslinks were identified in the different allosteric states of
GlyR. Residue 59 is shown to uniquely form an inter-subunit crosslink from 41C in the
desensitized state and a residue within the 28-34 region forms unique inter-subunit
crosslinks in the open state. In addition, the region between 202-206 is a unique intersubunit crosslink identified in the open state within the crosslinker distance of 419. Along
with the unique crosslinks identified in the different states of GlyR various common sites
were identified that are present within the crosslinker distances in all the three states of
GlyR both from 41 and 419 sites. Given the hypothesized unblooming of the ECD of GlyR
upon glycine binding by the bend/twist at the ECD-TM (pre-M1) interface and by
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stabilizing interactions in M2-M3 loop [136], our studies identified sites within the
crosslinker distance at both the pre M1 region and M2-M3 loop regions. The residues in
pre-M1 loop 212-218 shown to be present within the crosslinker distance of 419 in both
resting and open state of hGlyR. It is interesting to notice that these sites are also identified
within crosslinking distance of 41C in desensitized and open conformations. Overall, our
data suggests that CX-MS is capable of sensitively detecting the subtle changes in the
receptor allostery. Obtaining reproducible common crosslinks from studies at two sites (41
and 419) and crosschecking with the distances between residues in the known structures of
pLGICs gives us confidence in the data generated by mass spectrometry coupled with
crosslinking.
MS/MS data generated is also capable of identifying the allosteric changes in β
sheets of the ECD upon ligand binding. For example, in H419C studies peptide 3-20 is
identified within the crosslinker distance of 419C in MS analysis. Upon subjecting the
peptide to targeted MS/MS analysis, the crosslinker is further refined to occur between
positions 17-20 in resting state, position 20 in the desensitized state and at either position
3-4 in the open state, suggesting subtle movements of the β sheets of the ECD upon gating
and desensitization. Another example is that although 34-59 peptide is identified as massshifted crosslinked peptide within crosslinking distance of 41C, upon MS/MS analysis the
34-36 region is identified as the site of crosslinking in resting state while 58-59 and 65 sites
are identified in the desensitized and open states, respectively. In conclusion, this study
shows that CX-MS can provide a large number of distance constraints that may be useful
in validating and/or refining structural models and may assist in modeling on allostery.

This method also proved to be efficient in obtaining reliable and reproducible
structural data at the flexible regions of the protein (C-terminal loop (site 419) in this case)
that is otherwise vomited in all the other major methods used for structural determination.
Further systematic crosslinking studies at various sites would then yield a network of
crosslinks that can identify subtle allosteric changes and provide molecular determinants
of the receptor to further model/refine the existing models of full-length hGlyR.
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Quantitation of the frequency of the random crosslinking events will help us understand
the stability of the regions in the protein in its different conformations.
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CHAPTER 4

4.1 Concluding remarks
Successful generation of functional IVM sensitive (F207A/A288G) background and
addition of single cysteines at the sites 41 and 419 aided in obtaining a network of unique
and common inter and intra subunit crosslinks in conducting state of hGlyR in the presence
of nM concentrations of IVM. We have developed CX-MS using MTS-benzophenone as
crosslinker as an efficient method to map the structure of hGlyR in resting state identifying
the crosslinks within the crosslinker distance of sites 41 and 419. While MS analysis
identified the crosslinked peptides, MS/MS analysis further refined the sites of crosslinking
to a single residue in most cases and a shorter peptide in some cases. These sites allowed
for gaining insight into pre-M1 region and flexible C-terminal loop. The data obtained
through CX-MS identified both inter- and intra-subunit crosslinks within the crosslinker
distance of sites 41 and 419 respectively.
CX-MS method developed to study the resting state of hGlyR has then been
successfully applied to the different conformational states of hGlyR (desensitized and
open). Unique crosslinks has been observed in the three states of GlyR distinguishing
subtle changes in protein conformation along with some common reproducible crosslinks
identified at both 41 and 419 sites. The identified sites of crosslinking were obtained within
10ppm for MS analysis and within 0.1Da in MS/MS analysis.
CX-MS has proven to be a complimentary technique to other structural methods
including X-ray crystallography, NMR, cryo-EM in obtaining distance constraint
information of the different conformational states of membrane proteins and demonstrates
as a potential technique in requiring low quantities of protein, to study any full length
membrane protein in its natural habitat. CX-MS is a promising technique in providing
structural information on the flexible loop regions (for example C-terminal loop of hGlyR
419 site) that is often truncated in other structural determinations.
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4.2 Future work
Future work will apply CX-MS to systematically introduced single cysteines in GlyR, to
generate a more comprehensive matrix of state-dependent distance constraints. This
information will be used to update and refine the models of GlyR in its different
conformational states. This approach is particularly useful in identifying networks of
constraints for flexible loops that may be poorly resolved in structural homologs. The
network of crosslinking data obtained from systematically adding cysteines in the receptor
in its three different states and by using varying lengths of crosslinker can yield information
on channel gating and desensitization.
While CX-MS of the systematically added cysteines can provide subtle changes in
the receptor upon ligand binding and desensitization, Luminescence resonance energy
transfer (LRET) can be a complimentary tool to study the global changes in the overall
receptor architecture and dynamics in real time and in its native environment. Future work
will include obtaining distance data on global conformational changes in the receptor
allostery.
Work on separating crosslinking peptides from non-crosslinked peptides post
trypsin digestion should be carried out. Reaction of biotin azide to alkyne active group of
crosslinker using click chemistry and using streptavidin column for enrichment caused ion
suppression and failure to identify crosslinked peptides in mass spec. exploring other tags
that react with alkyne tag and those that ionize well would solve the problem of ion
suppression and should successfully isolate the crosslinked peptides.
Data analysis of MS and MS/MS spectra showed that often times the sites of
crosslinking can be on neighboring residues of the same peptides. The current method
cannot separate the isobaric species. Liquid chromatography (front end) of the mass spec
method needs to be optimized to separate these isobaric species. Future work should also
focus on working on optimizing the collision energy (CE) based on the composition of the
peptide identified to further fragment it to ensure single site of crosslinking is identified
instead of refining the peptides to shorter peptides. Usage of Skyline software to predict
the CE of the peptide based on its composition could be helpful in identifying single site
of crosslinking in MS/MS studies.
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Further work will focus on quantitating the frequency of crosslinking events. Laser
induced fluorescence (LIF) method where a primary amine-reactive NDA that fluoresces
upon laser radiation can be used to quantitate the frequency of crosslinking on microfluidic
platform. LIF has been shown to quantitate NDA tagged primary amines in amol range
developed in the lab (Davic, PhD thesis, 2016) is a promising technique to quantitate the
crosslinking events.
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APPENDIX

5.1 Systematic addition of cysteines in human α1-GlyR to generate state-dependent
crosslinks to generate/refine GlyR models
Single cysteines have been added systematically into GlyR in both Cys null and IVM
sensitive (F207A/A288G) backgrounds. This will aid in generating crosslinking data of
GlyR in its different states. Putting together the crosslinking data will generate a more
comprehensive network of crosslinks that will be used to update/refine the structural
models of GlyR in its three functional states.

Fig. 19: Table (left) showing the successful addition of single cysteines in both IVM
sensitive and Cys null backgrounds. Figure (right) showing the single cysteines added (in
yellow) IVM sensitive mutation F207A and A288G is shown in blue.

The above mutations have been successfully made in both IVM and Cys null backgrounds
of GlyR and were successfully moved to bacmid for the infection of Sf-9 insect cells.
Twelve different protein samples have been harvested and successfully purified.
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Table 13: Concentration of mutated protein of GlyR by using modified
Lowry assay

The purified protein samples will be used to conduct crosslinking studies in resting (Cys
null GlyR with no ligand), desensitized state (Cys null GlyR with 10mM glycine) and open
state (IVM sensitive GlyR with 10nM IVM) and will then be subjected to CX-MS studies.
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5.2 Luminescence resonance energy transfer (LRET) studies of mutant human α1GlyR to understand global changes in a state-dependent manner
5. 2.1 Background on Luminescence resonance energy transfer (LRET)
Fluorescence resonance energy transfer (FRET) is based on the principle of non-radiative
energy transfer between two fluorophores (donor and acceptor). Energy transfer occurs
when the donor is in proximity with acceptor molecule and when the emission spectrum of
the donor fluorophore overlaps with the absorption spectrum of the acceptor fluorophore
uses the same principle as FRET with an exception using a molecule from lanthanide series
as a chelated donor (typically terbium chelate) [145]. The chromophore group present in
the chelate molecule exhibits longer lifetimes that allows for sensitized measurements in
living cells. Usage of a chelate also allows for the usage of multiple acceptor molecules.
LRET can be used to measure the distances within 10-100Å to allow for efficient energy
transfer between donor and acceptor molecules [146].

Fig. 20: Figure showing the principle of FRET and equations used
to measure distances and FRET efficiency.
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5.2.2 Choice of fluorophores for LRET
Typically terbium chelate is used a donor fluorophore in LRET studies. The acceptor
fluorophores are selected based on the distance range which is slightly lower than the R0
of the fluorophore pair. Alexa, Atto and Fluo are used as acceptor dyes for this study.
Typically cysteines are introduced at the sites to be tagged with donor and acceptor
molecules and maleimide derived fluorophores are used to tag these cysteines. Although
LRET is capable of measuring distances in living cells it has to be noted that LRET doesn’t
yield absolute distances [147, 148].

Fig 21: Plot showing the emission spectrum of terbium cryptate donor and
absorption spectra of various acceptor dyes that have overlapping spectra.
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5.2.3 Methods
Mutant GlyR samples are expressed in Sf-9 insect cells using baculovirus expression using
MOI > 5. The cells are pre-labeled with 10mM iodoacetamide for 1hr at 27°C to block any
accessible cysteines prior to mutant GlyR expression. Post treatment, the cells are collected
by centrifugation for 5min at 1000xg, washed with serum-free medium to remove excess
iodoacetamide and then is resuspended in FBS-containing medium. The cells are then
allowed to express the mutant GlyR and is harvested 3 days post infection. At this point,
the only available cysteines for fluorophore labeling will be cysteines that are added into
GlyR.

The harvested cells are then washed with extracellular buffer and is labeled with
1:4 ratio of acceptor (fluo, atto, alexa) and donor (terbium chelate) for an hour in dark. The
cells are then washed with extracellular buffer and fluorescence lifetime measurements are
conducted.
5.2.4 Fluorescence lifetime measurements
Data was collected using Felix software (Photon Technologies) and analyzed using Origin
software. Donor only lifetimes were collected at 488nm and the emission of the acceptor
is collected at 515nm. The distances between the donor and acceptor is calculated using
the time constants of the donor fluorescence decay (τD) and the sensitized emission of the
acceptor due to energy transfer from donor (τDA). The data is then fit into double
exponential decay arising from the symmetry (pentameric) of the GlyR. LRET
measurements gives an average of global conformational changes.
5.2.5 Results
LRET measurements were conducted on single cysteines placed at 41, 116 and 200
positions in IVM sensitive (F207A/A288G) background in hGlyR.
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Fig. 22: Double exponential decay of IVM A41C mutation in the absence of ligand,
presence of glycine and ivermectin respectively.
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Fig. 23: Distances obtained in LRET studies in IVM A41C mutation in the absence of
ligand, presence of glycine and ivermectin respectively.
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Fig. 24: Double exponential decay of IVM K200C mutation in the absence of ligand,
presence of glycine and ivermectin respectively.
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Fig. 25: Distances obtained in LRET studies in IVM K200C mutation in the absence of
ligand, presence of glycine and ivermectin respectively.
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Fig. 26: Double exponential decay of IVM K116C mutation in the absence of ligand,
presence of glycine and ivermectin respectively.
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Fig. 27: Distances obtained in LRET studies in IVM K116C mutation in the absence of
ligand, presence of glycine and ivermectin respectively.
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Table 14: Table showing the relative distances obtained at sites 41, 116 and 200 in IVM
background.

5.2.6 Conclusions
Relative distances are measured using double exponential decay in IVM sensitive 41, 116
and 200 respectively in the resting state (absence of ligand), desensitized (10mM glycine)
and conducting state (10nM IVM). The measured distances did not show significant
changes between the different states of GlyR.
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